<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04624815</url>
  </required_header>
  <id_info>
    <org_study_id>APHP190828</org_study_id>
    <secondary_id>IDRCB: 2019-A01976-51</secondary_id>
    <nct_id>NCT04624815</nct_id>
  </id_info>
  <brief_title>Factors Issued From Functional Exploration Associated to SAHOS in Asthmatic Children</brief_title>
  <acronym>SASTHMA</acronym>
  <official_title>Factors Issued From Functional Exploration Associated to SAHOS in Asthmatic Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is an increase in the prevalence of obstructive apnea-hypopnea syndrome (OSA) in&#xD;
      children for which the pathophysiological explanation is unknown. The main objective is to&#xD;
      compare pharyngeal collapsibility in asthmatic children with SHS score &gt; 2.75 or ≤ 2.75 (OSA&#xD;
      prediction score validated in French). Secondary objectives: Compare pharyngeal size,&#xD;
      tracheal size, loop gain and its components (controller, plant), lung volumes and expired and&#xD;
      nasal NO in asthmatic children with SHS score &gt; 2.75 or ≤ 2.75. The bias due to the possible&#xD;
      existence of an alveolar hyperventilation syndrome associated with asthma will be taken into&#xD;
      account.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Detailed measurements and questionnaires: Measurement of pharyngeal volume by acoustic&#xD;
      pharyngometry in sitting and lying position with calculation of pharyngeal compliance.&#xD;
      Measurement of ventilation (15 minutes) and transcutaneous PCO2 measurement, three apnea&#xD;
      tests at the end of the test, hyperventilation test. PFT with spirometry and static volume&#xD;
      measurement. Multiple flow measurement of exhaled NO with calculation of bronchial flow and&#xD;
      alveolar fraction of NO. Nasal NO measurement. Questionnaires for OSA: the Pediatric Sleep&#xD;
      Questionnaire (PSQ) and the SCR (Sleep Clinical Record). Questionnaires for functional&#xD;
      respiratory disorder: French hyperventilation questionnaire SHAPE and the Nijmegen score&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 20, 2020</start_date>
  <completion_date type="Anticipated">November 20, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 20, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>pharyngeal collapsibility pharyngeal collapsibility pharyngeal collapsibility</measure>
    <time_frame>1 year</time_frame>
    <description>Pharyngeal compliance will be measured using acoustic pharyngometry</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Asthma</condition>
  <condition>Obstructive Sleep Apnea Syndrome</condition>
  <eligibility>
    <study_pop>
      <textblock>
        asthmatic children&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Confirmed asthma established on the notion of typical respiratory functional signs and&#xD;
             the notion of reversibility of a bronchial obstruction on previous PFT and/or asthma&#xD;
             exacerbation diagnosed by the physician in an emergency room. Ongoing asthma treatment&#xD;
             (including SABA on demand)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  not asthmatic children&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Christophe DELCLAUX, MD-PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Public Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christophe DELCLAUX, MD-PhD</last_name>
    <phone>+1 40 03 41 90</phone>
    <email>christophe.delclaux@aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Robert Debre Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe Delclaux, MD PhD</last_name>
      <phone>+33 1 40 03 41 90</phone>
      <email>christophe.declaux@aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 15, 2020</study_first_submitted>
  <study_first_submitted_qc>November 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 12, 2020</study_first_posted>
  <last_update_submitted>October 15, 2021</last_update_submitted>
  <last_update_submitted_qc>October 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

